Harpoon Ventures, a San Diego-based venture capital firm, has raised a new $120 million fund as it continues to help early-stage technology startups win federal contracts, Fast Company reported Tuesday. Read...
Read MoreCars are lucrative yet fast-moving targets for hackers. As they transform from combustion engines into sophisticated computers-on-wheels, threat actors have a larger attack surface to exploit. However, the automotive industry has also invested considerably in securing cars, seeking to lock attackers out, both physically and virtually. Read more...
Read MoreCorrActions, a noninvasive neuroscience startup that uses sensor data to evaluate a user’s cognitive state due to drowsiness, alcohol, fatigue and other issues, today announced that it has raised a $2.7 million seed round. Early-stage fund VentureIsrael, seed fund Operator Partners and the Israeli Innovation Authority are backing the company, which is based out of OurCrowd’s Labs/02 incubator. Read...
Read MoreJERUSALEM, Feb. 11, 2021 /PRNewswire/ — BrainQ, the Israeli start-up with a therapeutic solution to reduce disability following stroke, announced today that the United States Food and Drug Administration (FDA) has designated its AI-powered technology as a Breakthrough Device. The designation, which was based on BrainQ’s latest randomized controlled clinical trial results for ischemic stroke patients, provides BrainQ with the opportunity to work closely with the FDA to expedite development plans and premarket clearance. Breakthrough status also gives BrainQ access to the new Medicare Coverage of Innovative Technology (MCIT) pathway, allowing for Medicare coverage to be provided concurrently with FDA market authorization. Read more...
Read MoreBayer AG’s impact investment arm is backing a company working to combat food-related allergies. Read more...
Read More
